EDGAR filings
Every filing EDGAR's full-index lists, from every filer: companies, insiders, funds and filing agents. A search that names no form type, ticker or filer CIK covers at most 31 days and defaults to the last 7.
EDGAR holds what was filed electronically. Electronic filing began in 1993 (the earliest filing here is of 1993-02-11) and was phased in filer by filer until May 1996: filings made on paper before 1993, and during the phase-in by a filer not yet on EDGAR, are not on EDGAR and therefore not here.
50 rows on this page.
| Filed | Form | Filer | Category | 8-K items / description | Accession |
|---|---|---|---|---|---|
| 2026-11-06 | SCHEDULE 13G/A |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0000312069-26-000266 | |
| 2026-11-05 | 10-Q |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Financial reports | 10-Q | 0001453687-26-000111 |
| 2026-11-05 | 8-K |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Current reports | 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits | 0001453687-26-000110 |
| 2026-09-29 | 8-K |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Current reports | 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits | 0001453687-26-000105 |
| 2026-08-13 | SCHEDULE 13G |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0000312069-26-000206 | |
| 2026-08-06 | 10-Q |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Financial reports | 10-Q | 0001453687-26-000101 |
| 2026-08-06 | 8-K |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Current reports | 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits | 0001453687-26-000100 |
| 2026-07-22 | SCHEDULE 13G/A |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0000019617-26-000272 | |
| 2026-06-17 | 8-K |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Current reports | 5.07 Submission of Matters to a Vote of Security Holders | 0001453687-26-000090 |
| 2026-06-09 | 144 |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0001950047-26-005808 | |
| 2026-06-09 | 8-K |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Current reports | 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits | 0001140361-26-024556 |
| 2026-06-02 | 144 |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0001950047-26-005471 | |
| 2026-05-26 | 8-K |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Current reports | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits | 0001453687-26-000087 |
| 2026-05-06 | SCHEDULE 13G/A |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0000315066-26-001134 | |
| 2026-04-30 | S-8 |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Registrations and prospectuses | 0001453687-26-000084 | |
| 2026-04-30 | 10-Q |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Financial reports | 10-Q | 0001453687-26-000082 |
| 2026-04-30 | 8-K |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Current reports | 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits | 0001453687-26-000081 |
| 2026-04-28 | DEF 14A |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Proxies | 0001453687-26-000072 | |
| 2026-04-28 | DEFA14A |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Proxies | 0001453687-26-000071 | |
| 2026-04-06 | 4 |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0002064832-26-000149 | |
| 2026-04-06 | 4 |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0002064832-26-000148 | |
| 2026-04-02 | SCHEDULE 13D/A |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0001193125-26-140633 | |
| 2026-03-30 | 8-K |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Current reports | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 0001453687-26-000068 |
| 2026-03-13 | SCHEDULE 13G |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0001642575-26-000003 | |
| 2026-03-13 | 4 |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0001453687-26-000066 | |
| 2026-03-09 | 10-K |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Financial reports | 10-K | 0001453687-26-000064 |
| 2026-03-09 | 8-K |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Current reports | 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits | 0001453687-26-000063 |
| 2026-02-05 | SCHEDULE 13G/A |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0000315066-26-000393 | |
| 2026-01-13 | 144 |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0001950047-26-000366 | |
| 2026-01-09 | 144 |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0001950047-26-000312 | |
| 2026-01-09 | 8-K |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Current reports | 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits | 0001453687-26-000051 |
| 2026-01-08 | 4 |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0001453687-26-000047 | |
| 2026-01-08 | 4 |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0001453687-26-000046 | |
| 2026-01-08 | 4 |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0001453687-26-000045 | |
| 2026-01-06 | 4 |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0001453687-26-000039 | |
| 2026-01-06 | 4 |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0001453687-26-000038 | |
| 2026-01-06 | 4 |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0001453687-26-000037 | |
| 2026-01-06 | 4 |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0001453687-26-000036 | |
| 2026-01-06 | 4 |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0001453687-26-000035 | |
| 2026-01-06 | 4 |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0001453687-26-000034 | |
| 2026-01-06 | 4 |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0001453687-26-000033 | |
| 2026-01-06 | 4 |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0001453687-26-000032 | |
| 2026-01-06 | 4 |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0001453687-26-000031 | |
| 2026-01-06 | 4 |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0001453687-26-000030 | |
| 2026-01-06 | 4 |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0001453687-26-000029 | |
| 2026-01-06 | 4 |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0001453687-26-000028 | |
| 2026-01-02 | 4 |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0001453687-26-000002 | |
| 2025-12-18 | 4 |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0001453687-25-000144 | |
| 2025-12-18 | 3 |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Ownership | 0001453687-25-000143 | |
| 2025-12-18 | 8-K |
RNAC
Cartesian Therapeutics, Inc.
CIK 1453687
|
Current reports | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.05 Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits | 0001453687-25-000140 |